Down-regulation of TGFβ1 and leptin ameliorates thioacetamide-induced liver injury in lipopolysaccharide-primed rats

Abstract

Pretreatment with a low dose of bacterial endotoxin (lipopolysaccharide, LPS) caused the reduction of cytochrome P450 (CYP) enzymes and inflammatory factors which are capable of protecting the liver from a lethal LPS challenge. However, the effects of LPS pretreatment on the expression of transforming growth factor β1 (TGFβ1) and leptin in thioacetamide (TAA)-induced liver fibrosis remain unknown. In this study, Sprague-Dawley rats were pretreated intraperitoneally with LPS (5 mg/kg body weight) for 24 h, and subsequently treated with TAA (200 mg/kg body weight/ 3 days) for 1 month to examine the effects of LPS on TAA-injured rats. LPS pretreatment was associated with lower granulation and lower (P < 0.05) GOT/GPT than in TAA-injured rats. The LPS-pretreated group had less collagen (Sirius red histochemical staining). Semiquantitative RT-PCR showed that the levels of collagen 3 and TGFβ1 mRNAs were lower (P < 0.05) in the liver of LPS-pretreated rats than in TAA-injured rats. TGFβRI mRNA in the liver of LPS-pretreated rats exceeded (P < 0.05) that in TAA-injured rats. LPS pretreatment reduced the leptin content (Western blot) below that of TAA-injured rats. These results imply that LPS pretreatment (endotoxin tolerance) alleviates the TAA-induced liver fibrosis of rats by reducing TGFβ1 and leptin content.

Keywords

Thioacetamide lipopolysaccharide endotoxin tolerance TGFβ1 leptin liver injury.

References

Hewett JA , Roth RA Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides . Pharmacol Rev 1993; 45: 382—411 .

Ganey PE , Roth RA Concurrent inflammation as a determinant of susceptibility to toxicity from xenobiotic agents . Toxicology 2001; 169: 195—208 .

Freudenberg MA , Galanos C. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages . Infect Immun 1988; 56: 1352—1357 .

Rockich K. , Blouin R. Effect of the acute-phase response on the pharmacokinetics of chlorzoxazone and cytochrome P-450 2E1 in vitro activity in rats . Drug Metab Dispos 1999; 27: 1074—1077 .

Liu J. , Sendelbach LE , Parkinson A. , Klaassen CD Endotoxin pretreatment protects against the hepatotoxicity of acetaminophen and carbon tetrachloride: role of cytochrome P450 suppression . Toxicology 2000; 147: 167—176 .

Friedman SL Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies . N Engl J Med 1993; 328: 1828—1835 .

Dobrovolskaia MA , Vogel SN Toll receptors, CD14, and macrophage activation and deactivation by LPS . Microbes Infect 2002 ; 4: 903—914 .

Cavaillon J-M. , Adrie C. , Fitting C. , Adib-Conquy M.

Endotoxin tolerance: is there a clinical relevance?

J Endotoxin Res 2003; 9: 101—107 .

Caballero ME , Berlanga J. , Ramirez D. et al. Epidermal growth factor reduces multiorgan failure induced by thioacetamide . Gut 2001 ; 48: 34—40 .

10.

Diez-Fernandez C. , Bosca L. , Fernandez-Simon L. , Alvarez A. , Cascales M. Relationship between genomic DNA ploidy and parameters of liver damage during necrosis and regeneration induced by thioacetamide . Hepatology 1993; 18: 912—918 .

11.

Landon EJ , Naukam RJ , Rama Sastry BV. Effects of calcium channel blocking agents on calcium and centrilobular necrosis in the liver of rats treated with hepatotoxic agents . Biochem Pharmacol 1986; 35: 697—705 .

12.

Ledda-Columbano GM , Coni P. , Curto M. et al. Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide . Am J Pathol 1991; 139: 1099—1109 .

13.

Fontana L. , Moreira E. , Torres MI et al. Serum amino acid changes in rats with thioacetamide-induced liver cirrhosis . Toxicology 1996; 106: 197—206 .

14.

Visen PK , Saraswat B. , Dhawan BN Curative effect of picroliv on primary cultured rat hepatocytes against different hepatotoxins: an in vitro study . J Pharmacol Toxicol Methods 1998; 40: 173—179 .

15.

Ramaiah SK , Apte U. , Mehendale HM Cytochrome P4502E1 induction increases thioacetamide liver injury in diet-restricted rats . Drug Metab Dispos 2001; 29: 1088—1095 .

16.

Wang L. , Sun J. , Li L. et al. Factors affecting hepatocyte viability and CYPIA1 activity during encapsulation . Artif Cells Blood Substit Immobil Biotechnol 2000; 28: 215—227 .

17.

Okamoto T. , Mitsuhashi M. , Fujita I. , Sindhu RK , Kikkawa Y. Induction of cytochrome P450 1A1 and 1A2 by hyperoxia . Biochem Biophys Res Commun 1993; 197: 878—885 .

18.

Juvonen RO , Kaipainen PK , Lang MA Selective induction of coumarin 7-hydroxylase by pyrazole in D2 mice . Eur J Biochem 1985; 152: 3—8 .

19.

Kocer Z. , Raunio H. , Pasanen M. et al. Comparison between cobalt and pyrazole in the increased expression of coumarin 7-hydroxylase in mouse liver . Biochem Pharmacol 1991; 41: 462—465 .

20.

Pellinen P. , Stenback F. , Rautio A. , Pelkonen O. , Lang M. , Pasanen M. Response of mouse liver coumarin 7-hydroxylase activity to hepatotoxins: dependence on strain and agent and comparison to other monooxygenases . Naunyn Schmiedebergs Arch Pharmacol 1993; 348: 435—443 .

21.

Niemela O. , Parkkila S. , Juvonen RO , Viitala K. , Gelboin HV , Pasanen M. Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases . J Hepatol 2000; 33: 893—901 .

22.

Weltman MD , Farrell GC , Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation . Gastroenterology 1996; 111: 1645—1653 .

23.

Woodcroft KJ , Novak RF Insulin differentially affects xenobiotic-enhanced, cytochrome P-450 (CYP) 2E1, CYP2B, CYP3A, and CYP4A expression in primary cultured rat hepatocytes . J Pharmacol Exp Ther 1999; 289: 1121—1127 .

24.

Gressner AM , Chunfang GA Cascade-mechanism of fat storing cell activation forms the basis of the fibrogenic reaction of the liver . Verh Dtsch Ges Pathol 1995; 79: 1—14 .

25.

Kershenobich D. Molecular biology in gastroenterology . Rev Invest Clin 2003; 55: 181—185 .

26.

Oneta CM , Dufour JF Non-alcoholic fatty liver disease: treatment options based on pathogenic considerations . Swiss Med Wkly 2002; 132: 493—505 .

27.

Ikejima K. , Honda H. , Yoshikawa M. et al. Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals . Hepatology 2001; 34: 288—297 .

28.

Honda H. , Ikejima K. , Hirose M. et al. Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver . Hepatology 2002; 36: 12—21 .

29.

Dai K. , Qi JY , Tian DY Leptin administration exacerbates thioacetamide-induced liver fibrosis in mice . World J Gastroenterol 2005; 11: 4822—4826 .

30.

Ikejima K. , Takei Y. , Honda H. et al. Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat . Gastroenterology 2002; 122: 1399—1410 .

31.

Fan S. , Weng CF Co-administration of cyclosporine an alleviates thioacetamide-induced liver injury . World J Gastroenterol 2005; 11: 1411—1419 .

32.

Camus-Randon AM , Raffalli F. , Bereziat JC , McGregor D. , Konstandi M. , Lang MA Liver injury and expression of cytochromes P450: evidence that regulation of CYP2A5 is different from that of other major xenobiotic metabolizing CYP enzymes . Toxicol Appl Pharmacol 1996; 138: 140—148 .

33.

Kirby GM , Chemin I. , Montesano R. , Chisari FV , Lang MA , Wild CP Induction of specific cytochrome P450s involved in aflatoxin B1 metabolism in hepatitis B virus transgenic mice . Mol Carcinog 1994; 11: 74—80 .

34.

Kirby GM , Pelkonen P. , Vatanasapt V. , Camus AM , Wild CP , Lang MA , Association of liver fluke (Opisthorchis viverrini) infestation with increased expression of cytochrome P450 and carcinogen metabolism in male hamster liver . Mol Carcinog 1994; 11: 81—89 .

35.

Gao C. , Kennedy S. , Ponder KP Lipopolysaccharide potentiates the effect of hepatocyte growth factor upon replication in lung, thyroid, spleen, and colon in rats in vivo . Mol Ther 2001; 3: 462—475 .

36.

Margenthaler JA , Landeros K. , Kataoka M. , Eilers M. , Ku G. , Flye MW Effects of endotoxin tolerance on Propionibacterium acnes-primed lipopolysaccharide hepatic injury . J Surg Res 2003; 112: 102—110 .

37.

Chieli E. , Malvaldi G. Role of the microsomal FAD-containing monooxygenase in the liver toxicity of thioacetamide S-oxide . Toxicology 1984; 31: 41—52 .

38.

Cascales M. , Martin-Sanz P. , Craciunescu DG et al. Alterations in hepatic peroxidation mechanisms in thioacetamide-induced tumors in rats. Effect of a rhodium(III) complex . Carcinogenesis 1991; 12: 233—240 .

39.

Paine Mji , Scrutton NS , Munro AW , Gutierrez A. , Roberts Gck , Wolf CR Electron transfer partners of cytochrome P450. In: de Montellano O. (ed) Cytochrome P450. New York: Kluwer/Plenum , 2005 ; 115—138.

40.

Date M. , Matsuzaki K. , Matsushita M. , Tahashi Y. , Furukawa F. , Inoue K. Modulation of transforming growth factor beta function in hepatocytes and hepatic stellate cells in rat liver injury . Gut 2000; 46: 719—724 .

41.

Armendariz-Borunda J. , Seyer JM , Kang AH , Raghow R. Regulation of TGF beta gene expression in rat liver intoxicated with carbon tetrachloride . FASEB J 1990; 4: 215—221 .

42.

Carr BI , Hayashi I. , Branum EL , Moses HL Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor . Cancer Res 1986 ; 46: 2330—2334 .

43.

Russell WE , Coffey Jr RJ , Ouellette AJ , Moses HL Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat . Proc Natl Acad Sci USA 1988; 85: 5126—5130 .

44.

Bedossa P. , Paradis V. Transforming growth factor-beta (TGF-beta): a key-role in liver fibrogenesis . J Hepatol 1995; 22: 37—42 .

45.

Barnard JA , Lyons RM , Moses HL The cell biology of transforming growth factor beta . Biochim Biophys Acta 1990; 1032: 79—87 .

46.

Massague J. The transforming growth factor-beta family . Annu Rev Cell Biol 1990; 6: 597—641 .

47.

Roulot D. , Sevcsik AM , Coste T. , Strosberg AD , Marullo S. Role of transforming growth factor beta type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats . Hepatology 1999; 29: 1730—1738 .

48.

Shirai Y. , Kawata S. , Tamura S. et al. Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases . Cancer 1994; 73: 2275—2279 .

49.

Javelaud D. , Mauviel A. Mammalian transforming growth factor-betas: Smad signaling and physio-pathological roles . Int J Biochem Cell Biol 2004; 36: 1161—1165 .

50.

Chen H. , Charlat O. , Tartaglia LA et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice . Cell 1996; 84: 491—495 .

51.

Lee GH , Proenca R. , Montez JM et al. Abnormal splicing of the leptin receptor in diabetic mice . Nature 1996; 379: 632—635 .

52.

Harvey J. , Ashford ML Leptin in the CNS: much more than a satiety signal . Neuropharmacology 2003; 44: 845—854 .

53.

Otte C. , Otte JM , Strodthoff D. et al. Expression of leptin and leptin receptor during the development of liver fibrosis and cirrhosis . Exp Clin Endocrinol Diabetes 2004; 112: 10—17 .

54.

Waelput W. , Verhee A. , Broekaert D. et al. Identification and expression analysis of leptin-regulated immediate early response and late target genes . Biochem J 2000; 48: 55—61 .

55.

Cressman DE , Diamond RH , Taub R. Rapid activation of the Stat3 transcription complex in liver regeneration . Hepatology 1995; 21: 1443—1449 .

56.

Wustefeld T. , Rakemann T. , Kubicka S. , Manns MP , Trautwein C. Hyperstimulation with interleukin 6 inhibits cell cycle progression after hepatectomy in mice . Hepatology 2000; 32: 514—522 .